Addiction Medicine Board Exam Preparation Track (2019)

The Board Exam Preparation Track is designed for physicians taking the Addiction Medicine Board Exam from the American Board of Preventive Medicine.

  • A goal is to improve pass rates by helping test takers focus on high-yield concepts and successful study methods.
  • Presented in question and video format for maximum retention.
  • Topics not covered in presentations will be identified.

It consists of:

  • Video presentations from 2019's Board Exam Review Track in Anaheim, CA (7 CME credits). Expert presenters outline key material and board-style questions on topics covered on the exam, test taking and study tips.  The material is ordered by topic and all questions feature references and explanatory notes. 
  • Interactive Self-Assessment (9 CME credits) featuring nearly 400 updated board-style questions with feedback and/or references for each, organized by topic areas similar to those on the ABPM exam. You may take the quiz multiple times to practice!
    The question bank was refreshed in 2018 by physicians in the field. If you have any questions or feedback about the question bank, please use the "Contact Us" tab above. 

PRICE: $750 (Non-Members) | $595 (Members)

Target Audience

  1. Those planning on taking the ABPM Addiction Medicine Board Exam. 
  2. Physicians and other clinicians who wish to conduct a self assessment of their knowledge of addiction medicine in order to identify areas for further study.

Learning Objectives

This course is designed to assist learners in assessing their competence in subject areas that comprise addiction medicine, and plan further study as needed.

Course summary
Available credit: 
  • 16.00 AMA Category 1
  • 16.00 Attendance
Course opens: 
Course expires: 
  1. Introduction | Mason Turner, MD
  2. Basic Science | Thomas Meeks, MD
  3. Opioids and Pain | Thomas Meeks, MD
  4. Alcohol | John Tsuang, MD
  5. Dual Diagnosis | John Tsuang, MD
  6. Cannabis | Mason Turner, MD
  7. Medical Presentations | Py Driscoll, MD
  8. Sedative Hypnotics | Angie Chen, MD
  9. Special Populations and Special Topics | Mason Turner, MD
  10. Nicotine | Dustin DeYoung, MD
  11. Psychosocial Treatments | Dustin DeYoung, MD
  12. Social Science | Marie Mulligan, MD
  13. Club Drugs, Hallucinogens, Stimulants | Marie Mulligan, MD

Chwen-Yuen Angie Chen, MD, FACP, FASAM
Dr. Chen is currently Medical Director of Chemical Dependency Clinics in Primary Care at Stanford University. She is a board member of CSAM as chair of communications, Editor of the CSAM newsletter, and oversees the Test Taking Track Board Review Question Bank.
No relevant financial relationships to disclose.

Dustin DeYoung, MD
Dr. DeYoung, MD, is a psychiatrist for the University of California, Los Angeles (UCLA) Behavioral Health Associates and a research physician for the UCLA Department of Family Medicine.
Disclosure: BDH Pharma, LLC: Ownership Interest (stocks, stock options, or other ownership interest excluding diversified mutual funds)

Py Driscoll, MD
Helen “Py” Driscoll, MD Consulting Physician in Internal Medicine and Addiction Medicine at Alta Mira Recovery Program in Sausalito California Dr. Driscoll has 21 years of experience at Alameda County Medical Center in Oakland where she completed her residency and later served as an attending hospitalist instructing a team of residents, interns, and medical students.
No relevant financial relationships to disclose.

Thomas W. Meeks, MD, FASAM
Dr. Meeks is Medical Director of the Addiction Recovery Treatment Services at the Sacramento VA Medical Center and Assistant Clinical Professor of Psychiatry at UC Davis.
No relevant financial relationships to disclose.

Marie A. Mulligan, MD
Dr. Mulligan has provided primary care to patients living with substance use disorders and their family members for more than twenty years. She worked at SRCH since 2006 providing primary care to primarily Spanish speaking and English-speaking patients, including those living with severe mental illness and homelessness.
No relevant financial relationships to disclose.

John Tsuang, MD
Dr. Tsuang is the director of the Dual Diagnosis Treatment Program at the Harbor/UCLA Medical Center. He is a Clinical Professor of Psychiatry at the UCLA School of Medicine.
No relevant financial relationships to disclose.

Mason S. Turner, MD, Chair
Mason Turner, MD, is a psychiatrist at the Maui Lani Medical Office. He served as director of outpatient mental health and addiction medicine for Kaiser Permanente Northern California.
No relevant financial relationships to disclose.

PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians.  CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

CSAM designates this educational activity/enduring material for a maximum of 16 AMA/PRA Category 1 Credits™. (Physicians should only claim credit commensurate with the extent of their participation in the activity.) This credit may also be applied to the CMA Certification in Continuing Medical Education.

NON-PHYSICIANS: The California Society of Addiction Medicine (CSAM) provides a certificate of attendance for this online course based upon the number of hours you participated, up to maximum of 16. 

Available Credit

  • 16.00 AMA Category 1
  • 16.00 Attendance


Please login or register to take this course.